PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 7 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Clinical evidence
Methanolic extracts of Juniperus communis needles showed activity against both antibiotic-sensitive and -resistant Staphylococcus aureus strains, with the soluble phenolic fraction playing an important role [PMID:19772344].
Phenolic extracts and essential oils from Juniperus oxycedrus needles affected the growth of L. monocytogenes, increasing the lag phase and decreasing the final cell load [PMID:35915316].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 20412646 (2010) — Targeted and non-targeted approaches for complex natural sample profiling by GCxGC-qMS. · Journal of chromatographic science
- 2.PMID: 19757408 (2010) — Implication of agathic acid from Utah juniper bark as an abortifacient compound in cattle. · Journal of applied toxicology : JAT
- 3.PMID: 38740163 (2024) — Exploring chitosan-plant extract bilayer coatings: Advancements in active food packaging via polypropylene modification. · International journal of biological macromolecules
- 4.PMID: 35915316 (2022) — Effects of Rubus fruticosus and Juniperus oxycedrus derivatives on culturability and viability of Listeria monocytogenes. · Scientific reports
- 5.PMID: 19772344 (2009)